What is the TRIUMPH Phase 3 trial
Retatrutide works on three receptors (GLP-1, GIP, and glucagon), while Semaglutide targets only GLP-1 and Tirzepatide targets two (GLP-1 and GIP)
Based on current trial timelines, approval is projected for late 2026 or 2027
Dont wait until youve regained all weight to make this decision
Nearly half of Britons (48%) and over a third of Americans (35%) feel anxious about stopping GLP-1s
Sokolov Frontiers in Medicine .2026;[Epub] CrossRef Panax notoginseng Saponins Ameliorate HighFat DietInduced Liver Injury via Mechanisms Involving TLR4Mediated Signaling and Lipid Metabolism Rong Li, Junyu Ma, Mengyao Li, Bangzhao Zeng, Xuexun Li, Xiaoyan Bi, Xin Zhao, Qin Gao, Yanling Yao, Yang Jiang, Chunmei Zhang, Fuli Ya Food Science & Nutrition .2026;[Epub] CrossRef MicroRNA-146a Protects against Hepatocellular Carcinoma through Suppression of CCL5 Morgan C